- Research article
- Open Access
Frequency of DEA 1 antigen in 1037 mongrel and PUREBREED dogs in ITALY
BMC Veterinary Researchvolume 13, Article number: 364 (2017)
The prevalence of dog erythrocyte antigen (DEA 1) in canine population is approximately 40–60%. Often data are limited to a small number of breeds and/or dogs. The aims of this study were to evaluate frequency of DEA 1 in a large population of purebred and mongrel dogs including Italian native breeds and to recognize a possible association between DEA 1 and breed, sex, and genetic and phenotypical/functional classifications of breeds. Frequencies of DEA 1 blood group collected from screened/enrolled blood donors and from healthy and sick dogs were retrospectively evaluated. The breed and the sex were recorded when available. DEA 1 blood typing was assessed by immunocromatographic test on K3EDTA blood samples. The prevalence of DEA 1 antigen was statistically related to breed, gender, Fédération Cynologique Internationale (FCI) and genotypic grouping.
Sixty-two per cent dogs resulted DEA 1+ and 38% DEA 1-. DEA 1- was statistically associated with Dogo Argentino, Dobermann, German Shepherd, Boxer, Corso dogs, the molossian dogs, the FCI group 1, 2 and 3 and the genetic groups “working dogs” and “mastiff”. DEA 1+ was statistically associated with Rottweiler, Briquet Griffon Vendéen, Bernese mountain dog, Golden Retriever, the hunting breeds, the FCI group 4, 6, 7 and 8 and the genetic groups “scent hounds” and “retrievers”. No gender association was observed.
Data obtained by this work may be clinically useful to drive blood donor enrollment and selection among different breeds.
Blood groups are defined according to antigenic and species-specific genetic markers localized on the surface of erythrocyte cell membranes [1, 2]. Canine blood groups have received international standardization and were classified using the acronym DEA (dog erythrocyte antigen) followed by a number [2,3,4,5]. Historically, DEA 1 system included the types DEA 1.1 and DEA 1.2 (and possibly DEA 1.3) [2, 5]. Virtually, all DEAs can induce alloantibody formation but the most immunogenic antigen seemed to be DEA 1.1 [2, 4]. Recently, the DEA 1 blood group system has been described as a complex autosomal dominant allelic system with varied surface antigen expression levels [7,8,9]. Then, a dog could be classified as DEA 1 negative (DEA 1-) or DEA 1 positive (DEA 1+) with weak to strong antigen expression [7, 8]. The proportion of DEA 1- and strong DEA 1+ dogs were recently reported to be far larger than those of weak and moderate DEA 1+ dogs .
The canine blood typing for the red blood cell antigens, other than DEA 1, can be done only by a laboratory. In clinical practice, for in-house canine blood group DEA 1 determination, commercial point-of-care typing tests i.e. typing cards and immunochromatographic strips, using murine monoclonal anti-DEA 1 antibodies, are available [7, 13,14,15].
The general prevalence of DEA 1 in canine population is approximately 40–60% [9, 16,17,18]. Information about frequency of DEA 1+ and DEA 1- blood group between breeds is available but often involved a limited number of breeds. Data have been reported in Japan , Brazil [17, 20], South Africa , Nigeria , Croatia [23, 24], US [16, 25], Portugal , Turkey , Spain , India , Switzerland , Romania  and North America .
The aims of this study were (1) to evaluate frequency of DEA 1 in a large population of purebred and mongrel dogs including Italian native breeds and (2) to recognize a possible association between DEA 1+ and DEA 1- blood groups and breed, sex and genetic and phenotypical/functional breed grouping.
Dogs, samples and DEA 1 antigen assessment
This is a cross-sectional study without an “a priori” definition of the sample. It includes data collected from January 2013 to December 2015 and obtained from dogs screened and/or enrolled as blood donors and from healthy or sick dogs evaluated during clinical activity. DEA 1 blood typing and breed were available in all the dogs, and sex in the majority of the cases. Data were obtained from the Canine Blood Bank at the Istituto Zooprofilattico Sperimentale delle Venezie (Padua, Italy) (n = 354), the Department of Veterinary Medicine, Unit of Transfusion Medicine at the University of Perugia (Italy) (n = 313), the Veterinary Laboratory “San Marco” (Padua, Italy) (n = 242) and the Department of Veterinary Medicine at the University of Milan (Italy) (n = 128).
Blood was collected from cephalic or jugular vein into K3EDTA tubes, stored at 4–6 °C and processed within 24 h of collection. DEA 1 blood group was determined using an immunochromatographic strip typing kit (Labtest DEA 1, Alvedia, Limonest, France) according to the manufacturer’s instructions. Based on the test results, the dogs were classified as DEA 1+ and DEA 1–. For DEA 1+ dogs the band strength was not assessed.
The differences of DEA 1 prevalence in relation to sex and breed were tested by chi-square test or Fisher’s exact test when appropriate. Data of the breeds represented by at least 15 dogs were used for breed statistical analysis referred to frequencies. Moreover for breed comparison, dogs were grouped following different criteria: i) based on Fédération Cynologique Internationale (FCI, http://www.fci.be/en/) breed classification (10 groups); ii) based on genetic grouping (10 groups) as reported by vonHoldt et al. (2010); iii) breeds with hunting function included in FCI group 6 (Scent hounds and related breeds), 7 (Pointing dog) and 8 (Retrievers-Flushing dogs-Water dogs) compared to non-hunting breeds; iv) molossian dogs belonging to both FCI group 2 (Pincher and Schnauzer-Molossoid breeds-Swiss Mountain and Cattle dogs) and group 9 (Companion and Toy dogs) compared to non-molossian dogs.
The Italian Maremma hound breed was not classified in a FCI group but it was considered as a hunting breed for statistical analysis.
Chi-square value, P value, odds ratios (OR) and their 95% confidence interval (95% CI) were calculated for each comparison made. In case of zero value, a unity was added to each number in the calculation of the ORs. The mongrels group was chosen as the reference group. For data concerning FCI and genetic group classification, every group was compared with the others and not with the mixed breed dogs.
In the present study, 1037 dogs were evaluated. They were mongrels (n = 205) and purebred (n = 832), male (n = 498) and female (n = 523). The sex was unknown for 16 dogs. Purebred dogs belonged to 88 breeds. Thirty-eight percent (396/1037) of all the dogs tested DEA 1- and 62% (641/1037) DEA 1+. The percentages remained the same considering the mongrel and purebred subgroups. Dogs belonging to 14 breeds were statistically analyzed. In Tables 1 and 2 the frequencies of DEA 1- and DEA 1+ dogs according to breed and subjected to statistical analysis were summarized and related to data available in literature (when referred at least to 15 dogs per breed). In Table 3 were reported the frequencies related to breeds not subjected to statistical analysis. DEA 1- blood group was observed in all the Dogo Argentino and in mostly Dobermann, German Shepherd, Boxer and Corso dogs. All Rottweiler, Dachshound, Italian Maremma hound, Grand bleu de Gascogne, Anglo-français de petit vénierie and mostly Briquet Griffon Vendéen, Bernese mountain dog, English Setter, Giura hound, Golden Retriever, Labrador Retriever, Pinscher/Zwergpinscher and Ariégeois dogs resulted DEA 1 + .
No difference in the prevalence of DEA 1 antigen was observed in relation to gender (p: 0.21, chi- square: 1.58, OR: 0.843, 95% CI: 0.65–1.09).
The hunting dogs (n = 392, breeds n = 33) resulted statistically associated with DEA 1+ (81%; p < 0.01, chi- square: 121.92, OR: 5.54, 95% CI: 4.04–7.60). The molossian dogs (n = 158, breeds n = 16) resulted statistically associated with DEA 1- (67%; p < 0.01, chi-square: 68.18, OR: 4.41, 95% CI: 3.05–6.38).
All purebred dogs were classified based on FCI groups and dogs belonging to 42 breeds (n = 468) were classified according to the genetic groups proposed by vonHoldt et al. (2010). Based on FCI classification dogs belonging to groups 1 “Sheepdogs and cattledogs, except swiss cattledogs” (72/89, 81%), 2 “Pinscher and Schnauzer-Molossoid and swiss mountain and cattledogs” (136/254, 53%) and 3 “Terriers” (18/30, 60%) were more likely to be DEA 1- (p < 0.01). Dogs belonging to groups 4 “Dachshunds” (11/11, 100%), 6 “Scent hounds and related breeds” (129/157, 82%), 7 “Pointing dogs” (51/60, 85%), and 8 “Retrievers – Flushing dogs – Water dogs” (131/167, 78%) were more likely DEA 1+ (p < 0.01). Dogs belonging to genetic groups “working dogs” (77/91, 85%) and “mastiff-like” (36/51, 71%) were significantly more likely to be DEA 1- (p < 0.01) while dogs belonging to genetic groups “scent hounds” (47/51, 92%) and “retrievers” (152/191, 80%) were significantly more likely to be DEA 1+ (p < 0.01).
The present study reports data about DEA 1 frequency obtained from a large canine population including purebred dogs belonging to 88 breeds and tested with a commercial immunochromatographic kit. Few reports are available on breed-specific DEA 1 frequencies, often involving a limited number of dogs and breeds. They were reported in Japan , Brazil [17, 20], South Africa , Portugal , Spain [18, 31, 32], Switzerland  and India . A large survey of dogs has been performed in the US but the detailed results were not published .
The DEA 1 antigen was present in the 62% of the dogs included in this study without difference between mongrel and purebred subgroups. In agreement with our results, canine population frequencies range between 53% in Switzerland  and 61% in Brazil . In contrast, lower percentages are reported in US (42%)  and Japan (44%) . In mongrels, inhomogeneous results are published, with DEA 1+ dogs ranging from 48  to 90% .
Considering breed-specific frequency results, DEA 1- group was statistically associated with Dogo Argentino, Dobermann, German shepherd, Boxer and Corso dogs. Frequencies obtained agree with those previously reported (Table 1). Only for German Shepherd dogs frequencies of 100% and 70% of DEA 1+ were reported in Brazil  and India  respectively.
DEA 1+ blood group resulted statistically associated with Rottweiler, Briquet Griffon Vendéen, Bernese mountain dog and Golden Retriever breeds. Moreover dogs belonging to English setter, Labrador Retriever, and Ariégeois resulted prevalently DEA 1+ with frequencies ranging from 73 to 94%. Our results were in agreement with data reported elsewhere for Golden retriever  and Bernese mountain dog . Our Rottweiler were 100% DEA 1+ as reported in Brazil , even if elsewhere 12–22% of DEA 1- dogs were described [20, 21]. To the best of our knowledge, this is the first data about DEA 1 frequency for Briquet Griffon Vendéen, and Ariégeois. More extensive surveys would be strongly required to confirm the results of the present work, especially for breeds represented by a low number of dogs.
The discrepancies observed in our frequencies referred to mongrel and some purebred dogs compared to other studies could be related to the geographical different expression of the antigen as previously hypothesized [26, 33]. The performance of the diverse DEA 1 blood typing tests used in the different works published worldwide, may be also considered as a possible explanation. Even though no currently accepted gold standard for DEA 1 blood typing is available , the kit used in the present work seems to have the better performance. In fact when compared with other methods (i.e. card agglutination assay or gel-based method), it resulted specific and less subjective than the sensitive typing cards . Moreover, recent flow cytometric typing studies demonstrated a significant correlation with chromatographic strips for DEA 1 assessment, using the same monoclonal anti DEA 1 antibody [7, 8]. A possible limitation of the present study may be that only one blood typing method was used both in healthy and sick animals. Since it is a retrospective study, no information about the presence and the severity of anemia of ill dogs are available. The reduction of PCV has been reported to cause a decrease in the intensity of the DEA 1 band. [15, 34]. Consequently, in our survey a limited number of false negative results could not be excluded. Studies including dogs of different geographical area, obtained with the same test and, possibly, with the band straight assessment should be helpful to reduce influences (i.e few breeders, dogs closely related, test performance) on DEA 1 frequency referred to breed.
The FCI nomenclature splits purebred dog into ten groups based on morphology, current use and historical criteria. Recently, genetic diversity of dog breeds was evaluated and surprisingly a correspondence between genetic and phenotypical/functional breed grouping was observed with some exception . Dogs were accurately assigned to their breed >99% of the time  and the various breeds related one to another . Related groups of breed were defined by these studies and a correlation with breed genetic relatedness, morphological features and geographic origin was observed [36, 37]. Dogs belonging to our database were classified based on FCI groups and genetic groups involving breeds that clustered together as previously reported . Remarkably dogs belonging to FCI groups 1 and 2 resulted statistically more likely to be DEA 1- and dogs belonging to groups 4, 6, 7, 8 resulted more likely to be DEA 1+. In addition dogs belonging to genetic groups “working dogs” and “mastiff-like” resulted more likely DEA 1- and the groups “scent hounds” and “retriever” were more likely DEA 1+ .
Furthermore, molossoid dogs resulted statistically associated to DEA 1- blood group while dogs belonging to hunting breeds were significantly associated with DEA 1+ blood group. More data have to be collected to confirm this observation.
Frequency of only DEA 1 antigen was studied in the present work. Extended canine blood groups assessment including DEA other than 1 should be performed on candidate blood donor but it was not easily available for clinicians. In the clinical practice only DEA 1 kits are commercially available and could be used before the transfusion to test donor and recipient. Consequently the resulted reported in the present large canine population study could be exploited by clinicians to choose the most suitable dog to test in order to find the right candidate blood donor quickly.
The present study provides data on the frequency of DEA 1 antigen in a large number of dogs and confirms a broad variability among breeds. In fact, some breeds show high frequency of DEA 1- subjects resulting more susceptible to immunization when they receive blood from an incompatible donor.
In the routine activity of clinicians and of canine blood bank, our results may be valuable to drive blood donor enrollment and selection among different breeds.
- 95% CI:
95% confidence interval
Dog erythrocytes antigen.
Fédération Cynologique Internationale.
Vriesendorp HM, Westbroek DL, D'Amaro J, van der Does JA, van der Steen GJ, van Rood JJ, Albert E, Bernini L, Bull RW, Cabasson J, Epstein RB, Erikson V, Feltkamp TE, Flad HD, Hammer C, Lang R, Largiadér F, von Loringhoven K, Los W, Meera Khan P, Saison R, Serrou B, Schnappauf H. Joint report of 1st international workshop on canine Immunogenetics. Tissue Antigens. 1973;3(2):145–63.
Giger U. Blood typing and crossmatching to ensure blood compatibility. In: Bonagura, J.D., Twedt, D.C. (Eds), Kirk’s Current Veterinary Therapy. Saint Louis; 2015. web chapter 26.
Hale AS. Canine blood groups and their importance in veterinary transfusion medicine. Vet Clin North Small Anim Pract. 1995;25(6):1323–32.
Hohenhaus AE. Importance of blood groups and blood type antibodies in companion animals. Trasfus. Med Rev. 2004;18(2):117–26.
Davidow B. Transfusion medicine in small animals. Vet Clin Small Anim. 2013;43:735–56.
Ekiz EE, Arslan M, Ozcan M, Gultekin GI, Gulay OY, Kirmizibayrak T, Giger U. Frequency of dog erythrocytes antigen 1.1 in 4 breeds native to different areas in Turkey. Vet Clin Pathol. 2011;40(4):518–23.
Acierno MM, Raj K, Giger U. DEA 1 expression on dog erythrocytes analyzed by immunocromatographic and flow cytometry techniques. J Vet Intern Med. 2014;28:592–8.
Polak K, Acierno MM, Raj K, Mizukami K, Siegel DL, Giger U. Dog erythrocyte antigen 1: mode of inheritance and initial characterization. Vet Clin Pathol. 2015;44(3):369–79.
Euler CC, Lee JH, Kim HY, Raj K, Mizukami K, Giger U. Survey of two new (Kai 1 and Kai 2) and other blood groups in dogs of North America. J Vet Intern Med. 2016;30:1642–7.
Blais MC, Berman L, Oakley DA, Giger U. Canine dal blood type: a red cell antigen lacking in some Dalmatians. J Vet Intern Med. 2007;21:281–6.
Goulet S, Blais MC. Characterization of anti-Dal allonatibodies following sensitization of two Dal-negative dogs. Vet Pathol. 2017:1–8.
Goulet S, Giger U, Arsenault J, Abrams-Ogg A, Euler CC, Blais MC. Prevalence and mode of inheritance of the Dal blood group in dogs in North America. J Vet Intern Med. 2017;31:751–8.
Andrews GA, Chavey PS, Smith JE. Production, characterization, and applications of murine antibody to dog erythrocytes antigen 1.1. J Am Vet Med Assoc. 1992;201(10):1549–52.
Giger U, Stieger K, Palos H. Comparison of various canine blood-typing methods. Am J Vet Res. 2005;66(8):1386–92.
Seth M, Jackson KV, Winzelberg S, Giger U. Comparison of gel column, card, and cartridge techniques for dog erythrocytes antigen 1.1 blood typing. Am J Vet Res. 2012;73(2):213–9.
Hale AS, Werfelmann J, Lemmons M, Smiler B, Gerlach J. An evaluation of 9570 dogs by breed and dog erythrocytes antigen typing (abstract). J Vet Intern Med. 2008;22:740.
Sinnot Esteves V, de Almeida LL, Serina Lasta C, Pedralli V, González FHD. Frequencies of DEA blood types in a purebred canine blood donor population in Porto Alegre, RS. Brazil Pesq Vet Bras. 2011;31(2):178–81.
Mesa-Sanchez I. Ruiz de Gopegui-Fernández R, Granados-Machuca MM, Galan-Rodriguez a. Prevalence of dog erythrocytes antigen 1.1 in galgos (Spanish greyhounds). Vet Rec. 2014;174:351–4.
Ejima H, Kurokawa K, Ikemoto S. Phenotype and gene frequencies of red blood cell groups in dogs of various breeds reared in Japan. Jpn. J Vet Sci. 1986;48(2):363–8.
Novais AA, Santana AE, Vicentin LA. Prevalence of DEA1 canine blood group system in dogs (Canis familiaris, Linnaeus, 1758) reared in Brazil. Braz. J vet res. Anim Sci. 1999;36(1):23–7.
van der Merwe LL, Jacobson LS, Pretorius GJ. The breed prevalence of dog erythrocytes antigen 1.1 in the Onderstepoort area of South Africa and its significance in selection of canine blood donors. Jl S Afr vet Ass. 2002;73(2):53–6.
Nottidge HO, Omobowale TO, Washio M, Ajadi RA, Toizumi S, Takahashi K. The prevalence of the dog erythrocyte antigen 1 (DEA 1.1 and 1.2) in Nigerian indigenous dogs. Folia Vet. 2006;50(2):66–8.
Gračner D, Bedrica L, Labura Č, Matičić G, Gračner G, Samardžija M. Blood groups and haematology in Istrian pointer. Vet Arhiv. 2007;77(2):95–102.
Živčić V, Bedrica L, Šperanda M, Gračner D, Bošković T, Florijančić T, Didara M. Prevalence of DEA 1.1 blood group in Croatian indigenous breeds of dogs: Pasavaz hound and Tornjak hound. Vet Arhiv. 2013;83(6):633–8.
Iazbik MC, O’Donnell M, Marin L, Zaldivar S, Hudson D, Couto CG. Prevalence of dog erythrocytes antigens in retired racing greyhounds. Vet Clin Pathol. 2010;39(4):433–5.
Ferreira RRF, Gopegui RR, Matos AJF. Frequency of dog erythrocytes antigen 1.1 expression in dogs from Portugal. Vet Clin Pathol. 2011;40(2):198–201.
Unny MN, Manju KM, Pilla US. Studies on the occurrence of dog erythrocytes antigen 1.1 in dog breeds of Kerala, India. Malay. J. Vet Res. 2014;5(2):11–3.
Riond B, Schuler E, Rogg E, Hofman-Lehmann R, Lutz H. Prevalence of dog erythrocytes antigen 1.1 in dogs in Switzerland evaluated with gel column technique. Schweiz Arch Tierheilkd. 2011;153(8):369–74.
Ognean L. Testing of some canine blood types in transfusion compatibility assessment. Pak Vet J. 2014;34(1):96–9.
Ortega C, de Blas I, Simón MC, Gironés O, Garcìa G, Alonso JL, Muzquiz JL, Ruiz I. Information program applied to the temporal study of pathological processes in animal populations. Rev Sci Tech. 2000;19(3):735–43.
Spada E, Proverbio D, Viñals Flórez LM. Serra Gómez de la Serna B, del Rosario Perlado Chamizo M, Perego R, Bagnagatti de Giorgi G, Baggiani L. prevalence of dog erythrocyte antigens 1, 4, and 7 in Galgos (Spanish greyhounds). J Vet Diagn Inv. 2015;27(4):558–61.
Spada E, Proverbio D, Viñals Flórez LM, Serra Gómez de la Serna B, Del Rosario Perlado Chamizo M, Baggiani L, Perego R. Prevalence of dog erythrocyte antigens 1, 4, and 7 in Podenco Ibicenco (Ibizan Hounds) from Ibiza Island. Vet Med Int. 2016;1048257:5.
Giger U, Gekens CJ, Callan MB, Oaklet DA. An acute hemolytic transfusion reaction caused by dog erythrocyte antigen 1.1 incompatibility in a previously sensitized dog. J Am Vet Med Assoc. 1995;206(9):1358–62.
Blois SL, Richardson DM, Abrams-Ogg ACG. Comparison of a gel column blood typing method and a point-of-care cartridge for dog erythrocytes antigen 1.1. J Vet Emerg Crit Care. 2013;23(3):340–3.
vonHoldt BM, Pollinger JP, Lohmueller KE, Lohmueller KE, Han E, Parker HG, Quignon P, Degenhardt JD, Boyko AR, Earl DA, Auton A, Reynolds A, Bric K, Brisbin A, Knowles JC, Mosher DS, Spady TC, Elkahloun A, Geffen E, Pilot M, Jedrzejewski W, Greco C, Randi E, Bannasch D, Wilton A, Shearman J, Musiani M, Cargill M, Jones PG, Qian Z, Huang W, Ding Z, Zhang Y, Bustamante CD, Ostrander EA, Novembre J, Wayne RK, Genome-wide SNP. Haplotype analyses reveal a rich history underlying dog domestication. Nature. 2010;464(8):898–903.
Parker HG, Kim LV, Sutter NB, Carlson S, Lorentzen TD, Malek TB, Johnson GS, DeFrance HB, Ostrander EA, Kruqliak L. Genetic structure of the purebred domestic dog. Science. 2004;304(5674):1160–4.
Parker HG. Genomic analyses of modern dog breeds. Mamm Genome. 2012;23(1–2):19–27.
Spada E, Proverbio D, Priolo V, Ippolito D, Baggiani L, Perego R, Pennisi MG. Dog erythrocytes antigens (DEA) 1, 4, 7 and suspected naturally occurring anti-DEA 7 antibodies in Italian Corso dogs. Vet J. 2017;222:17–21.
The authors are grateful to Dr. Gioia Capelli and Dr. Marco Caldin for the statistical support.
EC and MV designed the project and wrote the manuscript; AC, MTA, AM, TF, DP, ES, AS, FM provided data, contributed to their interpretation and revised the manuscript. All authors have read and approved the final manuscript.
No funding was available.
Availability of data and materials
All the data supporting the results are included in the article. The dataset are available from the corresponding author on reasonable request.
Ethics approval and consent to participate
The activity of the Canine blood bank of the Istituto Zooprofilattico Sperimentale delle Venezie has been approved by its Ethics Committee on 12 October 2011 (Session n. 3/2011).
The data reported in the present study have been taken during the blood banks activity and were performed for the patient’s benefit and diagnostic purposes only. Informed consent was obtained from the owners as required by the blood banks to become eligible donor.
Consent for publication
The authors declare that they have no financial or personal relationship(s) which may have inappropriately influenced them in writing this article.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The work was done at the Istituto Sperimentale Zooprofilattico delle Venezie (IZSVe), the Department of Veterinary Medicine, Unit of Transfusion Medicine, University of Perugia, the Veterinary Laboratory “San Marco” and Veterinary Medicine,Veterinary Transfusion Research Laboratory (REVLab), Department of Veterinary Medicine, University of Milan. The study was not supported by a grant or otherwise.